NCCN updates bladder cancer guidelines to include ImmunityBio's ANKTIVA

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/21/2026

1. TGT
2. EL
3. SPY
4. BILL
5. WMT
6. ADI
7. ROST
8. MRK
9. MRNA
10. LOW

Go back to NCCN updates bladder cancer guidelines to include ImmunityBio's ANKTIVA
(NASDAQ: IBRX) Delayed: 7.84 -0.29 (3.57%)
Previous Close $8.13    52 Week High $ 
Open $7.90    52 Week Low $ 
Day High $8.00    P/E N/A 
Day Low $7.74    EPS $ 
Volume 8,098,070